Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF.

ABSTRACT:

SUBMITTER: Zackova D 

PROVIDER: S-EPMC10997522 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature